Prof. Dr. Thomas V. Riley: "Alternative therapies for infectious diseases"

Biotechnological Hub of the NIB (BTH-NIB)

The purpose of the investment project BTH-NIB is the assurance of the appropriate infrastructural conditions for the use of research and developmental opportunities in the fields of operation of the NIB.

Play Video About project      Publication

Prof. Dr. Thomas V. Riley: "Alternative therapies for infectious diseases"

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInPrint me

National Institute of Biology kindly invites you to view the lecture: “Alternative therapies for infectious diseases”, by Prof. Dr. Thomas Riley iz University of Western Australiadr. The lecture took place on Thursday, the 26th May 2011, on the National Institut of Biology, Večna pot 111, in Ljubljana.

 

National Institute of Biology kindly invites you to view the lecture:


“Alternative therapies for infectious diseases”,


by Prof. Dr. Thomas Riley iz University of Western Australiadr.

The lecture took place on Thursday, the 26th May 2011, on the National Institut of Biology, Večna pot 111, in Ljubljana.

 
Abstract:

This presentation sas about the consequences of inappropriate use of antimicrobial agents and some of the alternative approaches to treating infectious diseases that are being investigated, like naturally occurring antimicrobials (such as honey and plant essential oils), probiotics (including faecal flora replacement therapy) and bacteriophage therapy. Despite the fact that these sorts of treatments are popular with patients, in many cases the science underpinning their use is poor or lacking. Because of the antimicrobial resistance crisis there is renewed interest in this area.


Prof. Thomas V Riley, University of Western Australia, Perth, Australia


After 15 years working in diagnostic laboratories and completing a PhD part-time at The University of Western Australia (UWA), Tom was appointed Senior Medical Scientist in Charge of the Department of Clinical Microbiology at Sir Charles Gairdner Hospital in Perth, Western Australia, in 1988. In 1995, was appointed as an Associate Professor in the Department of Microbiology at UWA, and Principal Research Scientist at the Western Australian Centre for Pathology & Medical Research. In 2002, he was awarded a Personal Chair at UWA. He has had a long standing interest in healthcare-related infections, particularly the diagnosis and epidemiology of Clostridium difficile infection, and the antimicrobial activity of Australian native plants. He has published over 250 book chapters and refereed journal articles.

 

The lecture was held in English.


 
Link to the Lecture - VideoLectures.net